Serex, Inc.

Serex, Inc. — FDA 510(k) Submissions

Serex, Inc. has submitted 5 FDA 510(k) premarket notifications since 1989, of which 5 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include System, Test, Beta-2-microglobulin Immunological, Enzyme Immunoassay, Cocaine And Cocaine Metabolites, Enzyme Immunoassay, Cocaine . Use the specialty filter in the sidebar to narrow results.